skip to main |
skip to sidebar
Paracetamol Overdose
- Overdose is 150 mg/kg (7.5, 9, 10.5 gram for 50, 60, 70 kg patient respectively)
Phase I:
- 12-24 hours
- GI symptoms, N/V, anorexia, diaphoresis, pallor
- coma is rare
- most patients recover and does not go beyond Phase I
Phase II
- if toxicity continues, this is the latent phase of up to 48 hours
- Symptoms abate and patient feels better BUT
rising and striking levels of AST/ALT, PT/INR, bilirubin, lactate, phosphate - RUQ pain due to liver enlargement and tenderness
- most patients does not go beyond this phase
Phase III
- rare, serious hepatic necrosis; 3-5 days after ingestion
- + jaundice, confusion, stupor, coagulation defect, hypoglycemia, encephalopathy, renal failure, cardiomyopathy
- death if it occurs is due to fulminant hepatic failure
- mortality rate for toxic level without treatment is 3-4%
- Paracetamol metabolism: in the liver
- 3 pathways for metabolism; (1) and (2) are major
(1) Glucoronidation: glucoronide conjugate (not toxic) -> cleared by the kidneys
(2) Sulfation: sulfate conjugate (not toxic) -> cleared by the kidneys
(3) Cytochrome p450: NAPQI (N-Acetyl P-benzoQuinone Imine) (toxic) -> conjugates with sulfhydryl group of glutathione -> excreted to kidneys
OD: glutathione is saturated with lots of NAPQI and is depleted
NAPQI is toxic to liver = hepatoxicity and nephropathy
- N-acetylcysteine (Mucomyst, Parvolex): precursor of Glutathione
Guidelines for Management of AOD (pdf)
- Acetaminophen level
- take assay at 4 hours post-ingestion or ASAP if more than 4 hours
- above 200 ug/mL at 4 hours or 50 ug/mL at 12 hours = hepatotoxic
- Rumack-Matthew normogram: in order to err on the safe side, treatment line is drawn 25% below Rumack-Matthew line
- if below treatment line, NAC is unnecessary, or if already started, may discontinue
- if above treatment line, NAC complete course should be given even subsequent levels are below treatment line
- If a patient presents within 4 hours, withhold NAC until levels are out, PROVIDED that initiation of treatment is not delayed beyond 8 hours post-ingestion
- If a patient presents more than 8 hours, start NAC REGARDLESS of amount ingested. Do not wait for assay.
- Management: ABCDEFG
(1) Activated Charcoal: 50 g if less than 4 hours ( >2 hours, data is limited)
- 1g/kg, resuspended with water to achieve 25% concentration, dose is 10:1 ratio of activated charcoal to toxin
- not absorbed: PHAILS
- Pesticides, Potassium
- Hydrocarbons
- Acids, Alkalis, Alcohol
- Iron, Insecticides
- Lithium
- Solvents
(2) N-acetylcysteine:
IV: total of 300 mg/kg in 24 hours
- 150 mg/kg + 200 mL 5% Dextrose in 15-60 mins
- 50 mg/kg + 500 mL 5% Dextrose in 4 hours
- 100 mg/kg + 1L 5% Dextrose in 16 hours
= anaphylactoid reaction: PFUN (Pruritus, Flushing, Urticaria, Nausea, etc)
Tx: Give slower
Oral: 140 mg/kg LD, then 17 doses of 70 mg/kg at 4-hour intervals
- total duration: 72 hours
- LABS
- healthy, asymptomatic patient presenting early, only acetaminophen level
- in symptomatic or with elevated acetaminophen, ALT and AST, then daily
- in patients with liver injury: bilirubin, PT/INR, creatinine, BUN, electrolytes, blood glucose, lactate, phosphate, pH tests
- For Extended Release tablets: take it at 4 hours post-ingestion as there is no protocol, but some do a second level 4-6 hours after first assay
- if either is above treatment line, start NAC
- if either is below, discontinue NAC if already started
- Special considerations:
- Children below 6yo, hepatotoxicity is rare due to different metabolism, same approach but different dose
- Pregnant: treat as non pregnant although NAC enters placental barrier
- >24 hours, ALT/AST should be taken; IV NAC improves survival for those on fulminant hepatic failure; Rumack-Matthew is useless
- Alcoholics: more prone to hepatotoxicity, but same approach
- Repeated supratherapeutic (chronic) OD: ingestion of toxic amounts over a period of longer than 8 hours
- Rumack-Matthew is useless
- NAC should be given if assay is >10 mg/L or with liver injury (AST/ALT)
- NAC for 12 hours, then evaluate
- may discontinue if clinically well, AST/ALT improving, assay <10>
-
No comments:
Post a Comment